-
Building Your Biotech Brand
By Paula Burton, Project Director In today’s competitive landscape, having a strong brand is no longer optional; it’s essential. Whether you are a startup or a long-established organisation, your brand shapes how you are understood by the world, how you stand out, and ultimately, how you grow. So how do you build a compelling biotech brand and what do you need to consider along the way? Why brand matters A successful brand…
-
Why media placements are making a comeback – and why your content strategy depends on them
Media placements in top-tier scientific, healthcare and national publications are experiencing a powerful resurgence. For biotech, pharma, med tech and deep- tech science brands, they have become one of the most undervalued yet highest impact components of an effective content ecosystem. Earned media now directly shapes AI answers New data confirms that authoritative third‑party coverage…
-
Communicating Med Tech Innovation: How to Stand Out in a Competitive Market
The UK med tech sector continues to demonstrate resilience and ambition. With an annual turnover of £34 billion and more than 4,400 companies driving research, development and commercialisation, innovation remains strong across diagnostics, remote monitoring, implantable devices and fast-growing fields such as women’s health and fem tech. In such a competitive landscape, even the most transformative technology can struggle to be heard. Strong, strategic communication is essential to help…
-
Camgenium Expands NHS Access to Advanced, Risk-Adjusted Clinical Audit Analytics
Cambridge, UK, 26th February 2026 / Sciad Communications / Camgenium is pleased to announce that it now offers NHS hospitals flexible, risk‑adjusted clinical audit reports, making advanced AI‑powered performance insights more accessible than ever. Camgenium’s detailed hospital clinical audit reports provide accurate and actionable insight into performance and trends through the analysis of individual patient…
-
Volta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026
Boston, MA and Boulder, CO – February 23, 2026 / Sciad Communications / Watchmaker Genomics / At the Advances in Genome Biology and Technology (AGBT) General Meeting 2026 in Orlando, FL, Volta Labs, a leader in next-generation sequencing (NGS) sample preparation automation, today announced the launch of the Callisto™ Complete Kit for DNA EF Library Prep. The new solution pairs Watchmaker Genomics’ best-in-class NGS…
-
Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample
Boulder, CO – February 17, 2026 / Sciad Communications / Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, for certain foundational CRISPR-Cas9 intellectual property for use in NGS library preparation. While CRISPR-Cas9 technologies are most commonly associated with their unique ability to find and cut for genome editing, Watchmaker is leveraging it in a fundamentally different…
-
Organic Social Isn’t Free
By Maria Taylor Organic social is one of the most misunderstood channels in B2B marketing. Some teams treat it like a lead machine: post consistently, say something “thought-leadery”, and inbound enquiries will follow. Others dismiss it entirely because it doesn’t behave like paid media, where you can spend money and predictably buy reach. The truth is far from…
-
Neupulse Raises £3 Million to Accelerate Delivery of its Neurotherapeutic Technology
Nottingham, UK – Thursday 12th February 2026 / Sciad Communications / Neupulse, a neurotherapeutics company focused on delivering innovative solutions to people with brain health conditions, like Tourette Syndrome, has announced it has successfully raised £3 million in new funding. The round was led by Eos Advisory and the Midlands Engine Investment Fund II, through appointed fund manager Mercia Ventures,…
-
Visby Medical Collaborates with Watchmaker Genomics to Enhance Respiratory Pathogen Detection in the At-Home Setting
San Jose, CA and Boulder, CO, February 5, 2026 – Visby Medical, a leading innovator in at-home PCR testing of infectious diseases, has announced a strategic collaboration with Watchmaker Genomics, a supplier of innovative products for molecular analysis, to develop next-generation diagnostic tests for respiratory pathogen detection in the at-home setting. This partnership pairs Visby…
-
Sciad Spotlight: What we’re excited about in life science communications in 2026
At the start of the year, we did a Q&A with two members of our team to pick their brains about trends shaping the industry, the projects that have made a real impact, and what they are most excited about in life science communications. Tarryn, Digital Manager, and Paula, Project Director, shared their perspectives on…